EE9700225A - Meetod diabetes mellituse raviks, kasutades KKF - Google Patents

Meetod diabetes mellituse raviks, kasutades KKF

Info

Publication number: EE9700225A
Authority: EE; Estonia
Prior art keywords: kkf; diabetes mellitus; treating diabetes; mammals; pharmaceutical compositions
Prior art date: 1994-10-13

Application number

EE9700225A

Other languages

English (en)

Inventor

Francis Pierce Glenn

Lea Aukerman Sharon

Original Assignee

Amgen Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-10-12

Publication date

1998-02-16

1995-10-12 Application filed by Amgen Inc. filed Critical Amgen Inc.

1998-02-16 Publication of EE9700225A publication Critical patent/EE9700225A/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Zoology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

EE9700225A 1994-10-13 1995-10-12 Meetod diabetes mellituse raviks, kasutades KKF EE9700225A (et)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US32347594A	1994-10-13	1994-10-13
US32334094A	1994-10-13	1994-10-13
US48782595A	1995-06-07	1995-06-07
PCT/IB1995/000992 WO1996011950A1 (en)	1994-10-13	1995-10-12	Method of treating diabetes mellitus using kgf

Publications (1)

Publication Number	Publication Date
EE9700225A true EE9700225A (et)	1998-02-16

Family

ID=27406268

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
EE9700081A EE03975B1 (et)	1994-10-13	1995-10-12	Keratinotsüüdi kasvufaktori analoogid
EE9700225A EE9700225A (et)	1994-10-13	1995-10-12	Meetod diabetes mellituse raviks, kasutades KKF

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EE9700081A EE03975B1 (et)	1994-10-13	1995-10-12	Keratinotsüüdi kasvufaktori analoogid

Country Status (23)

Country	Link
EP (2)	EP0785948B1 (et)
JP (2)	JP4426646B2 (et)
KR (1)	KR100278597B1 (et)
CN (1)	CN1168678A (et)
AT (2)	ATE237633T1 (et)
AU (1)	AU3707795A (et)
BG (2)	BG101392A (et)
BR (2)	BR9509269A (et)
CA (2)	CA2201940C (et)
CZ (3)	CZ98197A3 (et)
DE (2)	DE69530403T2 (et)
DK (2)	DK0804479T3 (et)
EE (2)	EE03975B1 (et)
ES (2)	ES2196082T3 (et)
FI (2)	FI971420A0 (et)
HU (2)	HU226168B1 (et)
NO (2)	NO971566L (et)
NZ (2)	NZ505502A (et)
PL (2)	PL320484A1 (et)
PT (2)	PT785948E (et)
SI (2)	SI0804479T1 (et)
SK (2)	SK43197A3 (et)
WO (2)	WO1996011950A1 (et)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2153816T3 (es)	1989-01-31	2001-03-16	Jeffrey S Rubin	Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
US7084119B2 (en)	1993-06-29	2006-08-01	Chiron Corporation	Truncated keratinocyte growth factor (KGF) having increased biological activity
EP1493812A3 (en)	1993-06-29	2006-02-08	Chiron Corporation	A truncated keratinocyte growth factor (KGF) having increased biological activity
PT785949E (pt) *	1994-10-13	2003-09-30	Amgen Inc	Metodo para purificar factores de crescimento de queratinocitos
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en) *	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
DE69603269T3 (de) *	1995-04-27	2007-02-22	Coöperatie Cosun U.A.	Derivate von inulin
SI0935652T1 (en) *	1996-10-15	2004-06-30	Amgen Inc.	Keratinocyte growth factor-2 products
ATE263239T1 (de) *	1996-10-15	2004-04-15	Amgen Inc	Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
US7495087B2 (en)	1997-07-14	2009-02-24	Bolder Biotechnology, Inc.	Cysteine muteins in the C-D loop of human interleukin-11
US7153943B2 (en)	1997-07-14	2006-12-26	Bolder Biotechnology, Inc.	Derivatives of growth hormone and related proteins, and methods of use thereof
DE69838552T2 (de)	1997-07-14	2008-05-21	Bolder Biotechnology, Inc., Louisville	Derivate des wachstumshormons und verwandte proteine
US20080076706A1 (en)	1997-07-14	2008-03-27	Bolder Biotechnology, Inc.	Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
KR20010033484A (ko)	1997-12-22	2001-04-25	휴먼 게놈 사이언시즈, 인크.	각질세포 성장 인자-2 제제
US6242666B1 (en) *	1998-12-16	2001-06-05	The Scripps Research Institute	Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US8288126B2 (en)	1999-01-14	2012-10-16	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
EP1144613B2 (en) *	1999-01-14	2020-05-06	Bolder Biotechnology, Inc.	Methods for making proteins containing free cysteine residues
US6248725B1 (en)	1999-02-23	2001-06-19	Amgen, Inc.	Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
JP2004526437A (ja) *	2001-02-06	2004-09-02	メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング	低減された免疫原性を有する修飾されたケラチノサイト成長因子（ｋｇｆ）
PL374269A1 (en) *	2001-08-21	2005-10-03	Chiron Corporation	Kgf polypeptide compositions
AU2007214362B2 (en) *	2001-08-21	2009-11-26	Novartis Vaccines And Diagnostics, Inc.	KGF polypeptide compositions
CA2589889C (en)	2004-12-15	2013-07-30	Amgen Inc.	Therapeutic formulations of keratinocyte growth factor
CN102242124B (zh) *	2010-05-10	2013-05-22	齐鲁制药有限公司	改造的角化细胞生长因子基因及其在酵母中的表达
KR102440312B1 (ko) *	2020-08-28	2022-09-05	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4959314A (en) *	1984-11-09	1990-09-25	Cetus Corporation	Cysteine-depleted muteins of biologically active proteins
JPH01137994A (ja) *	1987-08-10	1989-05-30	Shionogi & Co Ltd	ｒｅｇ蛋白質
WO1990000877A1 (en) *	1988-07-27	1990-02-08	Marjan International Pty Ltd	Carpet stretcher
ES2153816T3 (es) *	1989-01-31	2001-03-16	Jeffrey S Rubin	Adn que codifica un factor de crecimiento especifico contra celulas epiteliales.
JP3303211B2 (ja) *	1991-04-26	2002-07-15	武田薬品工業株式会社	ｂＦＧＦムテインおよびその製造法
HU220641B1 (hu) *	1993-03-26	2002-03-28	Amgen Inc.	Keratinocita növekedési faktor alkalmazása
US5348563A (en) *	1993-06-29	1994-09-20	Honeywell Inc.	Air purifying apparatus
EP1493812A3 (en) *	1993-06-29	2006-02-08	Chiron Corporation	A truncated keratinocyte growth factor (KGF) having increased biological activity
GB9315501D0 (en) *	1993-07-27	1993-09-08	Ici Plc	Surfactant compositions
AU7475694A (en) *	1993-08-02	1995-02-28	Prizm Pharmaceuticals, Inc.	Monogenous preparations of cytotoxic conjugates

1995
- 1995-10-12 BR BR9509269A patent/BR9509269A/pt not_active Application Discontinuation
- 1995-10-12 BR BR9509329A patent/BR9509329A/pt not_active Application Discontinuation
- 1995-10-12 DE DE69530403T patent/DE69530403T2/de not_active Expired - Lifetime
- 1995-10-12 SI SI9530728T patent/SI0804479T1/sl unknown
- 1995-10-12 SK SK431-97A patent/SK43197A3/sk unknown
- 1995-10-12 AT AT95934793T patent/ATE237633T1/de active
- 1995-10-12 FI FI971420A patent/FI971420A0/fi unknown
- 1995-10-12 KR KR1019970702343A patent/KR100278597B1/ko not_active Expired - Fee Related
- 1995-10-12 PT PT95934793T patent/PT785948E/pt unknown
- 1995-10-12 DE DE69535264T patent/DE69535264T2/de not_active Expired - Lifetime
- 1995-10-12 JP JP51307696A patent/JP4426646B2/ja not_active Expired - Fee Related
- 1995-10-12 EP EP95934793A patent/EP0785948B1/en not_active Expired - Lifetime
- 1995-10-12 CZ CZ97981A patent/CZ98197A3/cs unknown
- 1995-10-12 CA CA002201940A patent/CA2201940C/en not_active Expired - Fee Related
- 1995-10-12 WO PCT/IB1995/000992 patent/WO1996011950A1/en not_active Ceased
- 1995-10-12 CZ CZ20023953A patent/CZ297329B6/cs not_active IP Right Cessation
- 1995-10-12 NZ NZ505502A patent/NZ505502A/en not_active IP Right Cessation
- 1995-10-12 DK DK95934808T patent/DK0804479T3/da active
- 1995-10-12 AT AT95934808T patent/ATE342278T1/de active
- 1995-10-12 CN CN95196410A patent/CN1168678A/zh active Pending
- 1995-10-12 PT PT95934808T patent/PT804479E/pt unknown
- 1995-10-12 EE EE9700081A patent/EE03975B1/et not_active IP Right Cessation
- 1995-10-12 CA CA002202075A patent/CA2202075C/en not_active Expired - Fee Related
- 1995-10-12 SI SI9530654T patent/SI0785948T1/xx unknown
- 1995-10-12 EE EE9700225A patent/EE9700225A/et unknown
- 1995-10-12 ES ES95934793T patent/ES2196082T3/es not_active Expired - Lifetime
- 1995-10-12 AU AU37077/95A patent/AU3707795A/en not_active Abandoned
- 1995-10-12 PL PL95320484A patent/PL320484A1/xx unknown
- 1995-10-12 SK SK455-97A patent/SK284534B6/sk not_active IP Right Cessation
- 1995-10-12 EP EP95934808A patent/EP0804479B1/en not_active Expired - Lifetime
- 1995-10-12 CZ CZ0105097A patent/CZ297328B6/cs not_active IP Right Cessation
- 1995-10-12 ES ES95934808T patent/ES2273338T3/es not_active Expired - Lifetime
- 1995-10-12 WO PCT/IB1995/000971 patent/WO1996011949A2/en not_active Ceased
- 1995-10-12 HU HU9901255A patent/HU226168B1/hu not_active IP Right Cessation
- 1995-10-12 PL PL95319784A patent/PL182888B1/pl not_active IP Right Cessation
- 1995-10-12 JP JP51307796A patent/JP4216329B2/ja not_active Expired - Fee Related
- 1995-10-12 HU HU9901071A patent/HUT78050A/hu unknown
- 1995-10-12 DK DK95934793T patent/DK0785948T3/da active
1997
- 1997-04-04 NO NO971566A patent/NO971566L/no unknown
- 1997-04-04 NO NO19971568A patent/NO318761B1/no not_active IP Right Cessation
- 1997-04-07 BG BG101392A patent/BG101392A/xx unknown
- 1997-04-11 BG BG101408A patent/BG63167B1/bg unknown
- 1997-04-11 FI FI971536A patent/FI120040B/fi not_active IP Right Cessation
1999
- 1999-04-09 NZ NZ335109A patent/NZ335109A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU226168B1 (en)	2008-05-28
EP0804479A1 (en)	1997-11-05
NO971568L (no)	1997-06-12
CA2201940A1 (en)	1996-04-25
PL182888B1 (pl)	2002-03-29
CZ98197A3 (cs)	1998-11-11
FI971420A7 (fi)	1997-04-04
FI971420L (fi)	1997-04-04
NZ505502A (en)	2005-01-28
CZ105097A3 (cs)	1998-10-14
DK0785948T3 (da)	2003-08-04
JP4426646B2 (ja)	2010-03-03
ATE237633T1 (de)	2003-05-15
BG63167B1 (bg)	2001-05-31
DE69535264T2 (de)	2007-02-01
BG101392A (en)	1997-10-31
AU3708395A (en)	1996-05-06
SK45597A3 (en)	1999-02-11
CA2202075A1 (en)	1996-04-25
CZ297328B6 (cs)	2006-11-15
SI0785948T1 (en)	2003-08-31
PT804479E (pt)	2007-02-28
WO1996011949A2 (en)	1996-04-25
BG101408A (bg)	1997-12-30
EP0785948A1 (en)	1997-07-30
BR9509329A (pt)	1997-10-14
CN1168678A (zh)	1997-12-24
ES2196082T3 (es)	2003-12-16
SK43197A3 (en)	1999-03-12
NO971566L (no)	1997-04-14
ES2273338T3 (es)	2007-05-01
CA2201940C (en)	2009-05-12
NO318761B1 (no)	2005-05-02
WO1996011950A1 (en)	1996-04-25
SI0804479T1 (sl)	2006-12-31
EP0785948B1 (en)	2003-04-16
DE69530403D1 (de)	2003-05-22
FI120040B (fi)	2009-06-15
KR100278597B1 (ko)	2001-01-15
EP0804479B1 (en)	2006-10-11
PL319784A1 (en)	1997-08-18
NZ335109A (en)	2000-08-25
NO971568D0 (no)	1997-04-04
CZ297329B6 (cs)	2006-11-15
EE9700081A (et)	1997-10-15
NO971566D0 (no)	1997-04-04
JP4216329B2 (ja)	2009-01-28
FI971536L (fi)	1997-06-09
SK284534B6 (sk)	2005-06-02
DE69535264D1 (de)	2006-11-23
CA2202075C (en)	2003-12-09
DK0804479T3 (da)	2007-01-29
JPH10507080A (ja)	1998-07-14
EE03975B1 (et)	2003-02-17
AU3707795A (en)	1996-05-06
WO1996011949A3 (en)	1996-12-12
PL320484A1 (en)	1997-09-29
FI971536A0 (fi)	1997-04-11
ATE342278T1 (de)	2006-11-15
HUT78050A (hu)	1999-07-28
AU681546B2 (en)	1997-08-28
DE69530403T2 (de)	2003-10-30
FI971420A0 (fi)	1997-04-04
PT785948E (pt)	2003-09-30
JPH10507193A (ja)	1998-07-14
BR9509269A (pt)	1997-12-23
HUT78058A (hu)	1999-07-28

Publication	Publication Date	Title
EE9700225A (et)	1998-02-16	Meetod diabetes mellituse raviks, kasutades KKF
DE69027865D1 (de)	1996-08-22	ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
AU5624699A (en)	2000-03-21	Use of 5ht-6 antagonists
TR200100922T2 (tr)	2001-09-21	Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
ID29393A (id)	2001-08-30	Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
ES2194106T3 (es)	2003-11-16	.ompuestos de imidazol
DE59508891D1 (de)	2001-01-11	Hautpflegemittel
DE69827001D1 (de)	2004-11-18	Gewebedezellularization
BG102616A (en)	1999-04-30	Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
FR2491334B1 (et)	1983-09-23
ATE234614T1 (de)	2003-04-15	Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE69818809D1 (de)	2003-11-13	Verfahren zur behandlung von narbengewebe
SE9400524L (sv)	1995-08-17	Energipreparat
DE59106803D1 (de)	1995-12-07	Substituierte Pyrido-oxazine.
DE69734349D1 (de)	2006-02-23	Behandlung von knochenleiden mit adrenomedullin
ATE165594T1 (de)	1998-05-15	Triarylethylenderivate zur therapeutischen verwendung
IS5231A (is)	1999-10-26	Vefjaþáttur sem hefur áhrif á blóðæðarmyndun
UA15363A (uk)	1997-06-30	Засіб для лікуваhhя відкритих пошкоджеhь
DE59609482D1 (de)	2002-08-29	Anellierte beta-carboline